» Articles » PMID: 28011489

Prognostic Impact of CD163+ Macrophages in Tumor Stroma and CD8+ T-Cells in Cancer Cell Nests in Invasive Extrahepatic Bile Duct Cancer

Overview
Journal Anticancer Res
Specialty Oncology
Date 2016 Dec 25
PMID 28011489
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: The aim of this study was to examine the clinicopathological influence of tumor-infiltrating cluster of differentiation (CD) 163 macrophages and CD8 T-cells, and to clarify the prognostic effects of these cells in patients with invasive extrahepatic bile duct cancer (EHBC).

Materials And Methods: The numbers of CD8 T-cells in cancer cell nests and CD163 macrophages in tumor stroma were evaluated using immunohistochemistry in 101 resected EHBC specimens. Correlations with clinicopathological variables and overall survival were analyzed.

Results: Perihilar EHBC and perineural invasion were significantly associated with a low number of tumor-infiltrating CD8 T-cells. Poorly- differentiated histology and nodal metastasis were significantly associated with a high number of tumor-infiltrating CD163 macrophages. A combination of high number of CD8 T-cells and low number of CD163 macrophages was independently related to better overall survival in the whole patient cohort (hazard ratio=0.127, p<0.001) and in patients treated with adjuvant chemotherapy (hazard ratio=0.139, p=0.021).

Conclusion: Infiltrating CD163 macrophages in tumor stroma and CD8 T-cells in cancer cell nests have a prognostic impact in patients with EHBC following resection and also after adjuvant chemotherapy.

Citing Articles

The Immune-Genomics of Cholangiocarcinoma: A Biological Footprint to Develop Novel Immunotherapies.

Cammarota A, Balsano R, Pressiani T, Bozzarelli S, Rimassa L, Lleo A Cancers (Basel). 2025; 17(2).

PMID: 39858054 PMC: 11763448. DOI: 10.3390/cancers17020272.


Prognostic Significance of CD11b-, CD8-, and CD163-Positive Tumor-Infiltrating Immune Cells in Distal Bile Duct Cancer.

Choi J, Kim J, Lee K, Lee G, Hong M, Hwang H J Pers Med. 2024; 14(10).

PMID: 39452540 PMC: 11508419. DOI: 10.3390/jpm14101033.


Multi-Omics Profiling Unveils the Complexity and Dynamics of Immune Infiltrates in Intrahepatic Cholangiocarcinoma.

Li X, Wang Y, Guan R, Sheng N, Zhang S Biology (Basel). 2024; 13(10).

PMID: 39452125 PMC: 11504529. DOI: 10.3390/biology13100816.


Circulating Immune Cells Predict Prognosis and Clinical Response to Chemotherapy in Cholangiocarcinoma.

Shi H, Li Z, Zhu M Curr Med Chem. 2024; 32(3):595-607.

PMID: 38698750 DOI: 10.2174/0109298673296618240424095548.


Effect of 2-methoxyestradiol on mammary tumor initiation and progression.

Peta K, Durandt C, van Heerden M, Joubert A, Pepper M, Ambele M Cancer Rep (Hoboken). 2024; 7(4):e2068.

PMID: 38600057 PMC: 11006714. DOI: 10.1002/cnr2.2068.